Randomized Controlled Experiment of Dieting in Pairs
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02898844|
Recruitment Status : Completed
First Posted : September 13, 2016
Last Update Posted : September 13, 2016
|Condition or disease||Intervention/treatment||Phase|
|Dietary Modification||Behavioral: Mixed Diet Condition Behavioral: Both Diet Condition||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||164 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Randomized Controlled Experiment of Dieting in Pairs|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
No Intervention: Control Condition
Neither roommate dieted.
Experimental: Mixed Diet Condition
Low-calorie diet: One roommate in each pair was randomly assigned to a 1200-calorie/day diet, while the other roommate was instructed to eat normally.
Behavioral: Mixed Diet Condition
One roommate dieted and the other ate normally.
Experimental: Both Diet Condition
Low-calorie diet: Both roommates in each pair were randomly assigned to a 1200-calorie/day diet.
Behavioral: Both Diet Condition
Both roommates dieted.
- Psychological well-being measured via electronic questionnaires [ Time Frame: ~3 days after end of 3-week manipulation ]
- Weight loss measured via pounds [ Time Frame: ~3 days after end of 3-week manipulation ]
- Diet adherence measured via daily calorie counts [ Time Frame: up to 3-week ]
- Cortisol measured via 2 days diurnal cortisol [ Time Frame: 1 day after end of 3-week manipulation ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02898844
|Principal Investigator:||A. Janet Tomiyama, PhD||University of California, Los Angeles|